These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 9122147)
21. Atovaquone compared with dapsone for the prevention of Pneumocystis carinii pneumonia in patients with HIV infection who cannot tolerate trimethoprim, sulfonamides, or both. Community Program for Clinical Research on AIDS and the AIDS Clinical Trials Group. El-Sadr WM; Murphy RL; Yurik TM; Luskin-Hawk R; Cheung TW; Balfour HH; Eng R; Hooton TM; Kerkering TM; Schutz M; van der Horst C; Hafner R N Engl J Med; 1998 Dec; 339(26):1889-95. PubMed ID: 9862944 [TBL] [Abstract][Full Text] [Related]
22. [Therapy and prevention of pneumocystis carinii pneumonia]. Goebel FD; Bogner JR Internist (Berl); 1995 Dec; 36(12):1150-5. PubMed ID: 8567220 [No Abstract] [Full Text] [Related]
23. Prophylaxis of AIDS-related opportunistic infections (OIs). Current status and future strategies. Hardy WD AIDS Clin Rev; 1991; ():145-80. PubMed ID: 1651099 [No Abstract] [Full Text] [Related]
24. Prophylaxis for opportunistic infections in patients with HIV infection. Gallant JE; Moore RD; Chaisson RE Ann Intern Med; 1994 Jun; 120(11):932-44. PubMed ID: 8172439 [TBL] [Abstract][Full Text] [Related]
25. Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology Group. Chaisson RE; Keruly J; Richman DD; Moore RD Arch Intern Med; 1992 Oct; 152(10):2009-13. PubMed ID: 1417373 [TBL] [Abstract][Full Text] [Related]
26. Clinical manifestations of AIDS in the era of pneumocystis prophylaxis. Multicenter AIDS Cohort Study. Hoover DR; Saah AJ; Bacellar H; Phair J; Detels R; Anderson R; Kaslow RA N Engl J Med; 1993 Dec; 329(26):1922-6. PubMed ID: 7902536 [TBL] [Abstract][Full Text] [Related]
27. Intravenous pentamidine as an alternate for Pneumocystis carinii pneumonia prophylaxis in children with HIV infection. Gupta M; Stephenson K; Gauar S; Frenkel L Pediatr Pulmonol Suppl; 1997; 16():199-200. PubMed ID: 9443273 [No Abstract] [Full Text] [Related]
28. [Pneumocystis carinii pneumonia and HIV infection: diagnosis and treatment]. González-García J; Rubio García R; Antela López A; García Alcaide F Enferm Infecc Microbiol Clin; 1998; 16 Suppl 1():36-44. PubMed ID: 9859618 [TBL] [Abstract][Full Text] [Related]
29. [Incidence of bacterial pneumonia in HIV-positive patients treated with preventive co-trimoxazole or pentamidine]. Koch A; Kothe H; Braun J; Kämmerer R; Friedrich HJ; Dalhoff K Pneumologie; 1998 Nov; 52(11):614-21. PubMed ID: 9885511 [TBL] [Abstract][Full Text] [Related]
30. Systemic Pneumocystis carinii pneumonia prophylaxis with dapsone and pyrimethamine fails to protect against extrapulmonary pneumocystosis. Carlin EM; Coker RJ; Goldin RD; Harris JR Genitourin Med; 1993 Apr; 69(2):130-2. PubMed ID: 8509094 [TBL] [Abstract][Full Text] [Related]
31. [The prevention of Pneumocystis carinii pneumonia in HIV infection]. Rockstroh JK; Spengler U; Sauerbruch T Dtsch Med Wochenschr; 1993 Nov; 118(46):1694-7. PubMed ID: 8243242 [No Abstract] [Full Text] [Related]
32. [Primary and secondary prevention of Pneumocystis carinii pneumonia with pentamidine aerosol. Effectiveness, side effects and incidence of extrapulmonary Pneumocystis carinii manifestations]. Stoehr A; Plettenberg A; Albrecht H; Stellbrink HJ; Meigel W; Begemann F Med Klin (Munich); 1994 Mar; 89(3):132-5. PubMed ID: 8196573 [TBL] [Abstract][Full Text] [Related]
33. Administration of pyrimethamine/sulfadoxine for prevention of Pneumocystis carinii pneumonia in patients with AIDS. Bessesen MT; Miller LA; Cohn DL; Bartlett S; Ellison RT Clin Infect Dis; 1995 Mar; 20(3):730-1. PubMed ID: 7756514 [No Abstract] [Full Text] [Related]
34. Discontinuation of secondary prophylaxis against Pneumocystis carinii pneumonia in patients with HIV infection who have a response to antiretroviral therapy. Eight European Study Groups. Ledergerber B; Mocroft A; Reiss P; Furrer H; Kirk O; Bickel M; Uberti-Foppa C; Pradier C; D'Arminio Monforte A; Schneider MM; Lundgren JD; N Engl J Med; 2001 Jan; 344(3):168-74. PubMed ID: 11188837 [TBL] [Abstract][Full Text] [Related]
35. Discontinuing prophylaxis against Pneumocystis carinii pneumonia. Bender MA; Sax PE N Engl J Med; 2001 May; 344(21):1639; author reply 1640-1. PubMed ID: 11374364 [No Abstract] [Full Text] [Related]
36. Prevention and treatment of pneumocystis pneumonia. Masur H N Engl J Med; 1992 Dec; 327(26):1853-60. PubMed ID: 1448123 [No Abstract] [Full Text] [Related]
37. Discontinuation of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus type I-infected patients: the changes in opportunistic prophylaxis study. Mussini C; Pezzotti P; Govoni A; Borghi V; Antinori A; d'Arminio Monforte A; De Luca A; Mongiardo N; Cerri MC; Chiodo F; Concia E; Bonazzi L; Moroni M; Ortona L; Esposito R; Cossarizza A; De Rienzo B J Infect Dis; 2000 May; 181(5):1635-42. PubMed ID: 10823763 [TBL] [Abstract][Full Text] [Related]
38. [Prevention of Pneumocystis carinii pneumonia associated with HIV infection using pentamidine aerosols. Retrospective study of 465 cases]. Guinet F; Pialoux G; Trotot P; Chauvelle MT; Feuillie V; Sansonetti P; Dupont B Presse Med; 1994 Dec; 23(38):1747-52. PubMed ID: 7831262 [TBL] [Abstract][Full Text] [Related]
39. [Cerebral toxoplasmosis in HIV infected patients intolerant of cotrimoxazole]. Rabaud C; May T; Beuscart C; Reynes J; Leport C; Canton P Ann Med Interne (Paris); 1998 Mar; 149(2):62-6. PubMed ID: 11490526 [TBL] [Abstract][Full Text] [Related]